Literature DB >> 18300541

Racial differences in the prevalence of atrial fibrillation among males.

Ann M Borzecki1, D Keith Bridgers, Jane M Liebschutz, Boris Kader, Lewis E Kazis, Dan R Berlowitz.   

Abstract

BACKGROUND: Despite being the most common cardiac arrhythmia, little is known about racial differences in atrial fibrillation (AF) prevalence and whether differences persist after accounting for known risk factors.
METHODS: We identified male respondents to the 1999 Large Health Survey of Veteran Enrollees who had an AF diagnosis in the VA administrative database during the preceding two years.
RESULTS: Of 664,754 male respondents, 5.3% had AF. By race, age-adjusted prevalence was 5.7% in whites, 3.4% in blacks, 3.0% in Hispanics, 5.4% in native Americans/Alaskans, 3.6% in Asians and 5.2% in Pacific Islanders (p<0.001). Of predisposing conditions, whites were more likely to have valvular heart disease, coronary artery disease and congestive heart failure, blacks had the highest hypertension prevalence; Hispanics had the highest diabetes prevalence. Racial differences remained after adjustment for age, body mass index and these comorbidities. White males were significantly more likely to have AF compared to all races but Pacific Islanders [versus blacks, OR=1.84 (95% CI: 1.71-1.98); versus Hispanics, OR=1.77 (1.60-1.97); vs Native Americans, OR 1.15 [1.04-1.27]; versus Asians, OR=1.41 (1.12-1.77) versus Pacific Islanders, OR=1.16 (0.88-1.53)].
CONCLUSIONS: AF prevalence varies by race. White males have the highest AF burden even after adjustment for known risk factors. Recognition of the high AF prevalence, especially among whites, as well as native Americans and Pacific Islanders, should help guide provider practices for screening among older male patients. Further research is necessary to verify and establish reasons for these racial differences.

Entities:  

Mesh:

Year:  2008        PMID: 18300541     DOI: 10.1016/s0027-9684(15)31212-8

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  43 in total

1.  Validation of an atrial fibrillation risk algorithm in whites and African Americans.

Authors:  Renate B Schnabel; Thor Aspelund; Guo Li; Lisa M Sullivan; Astrid Suchy-Dicey; Tamara B Harris; Michael J Pencina; Ralph B D'Agostino; Daniel Levy; William B Kannel; Thomas J Wang; Richard A Kronmal; Philip A Wolf; Gregory L Burke; Lenore J Launer; Ramachandran S Vasan; Bruce M Psaty; Emelia J Benjamin; Vilmundur Gudnason; Susan R Heckbert
Journal:  Arch Intern Med       Date:  2010-11-22

2.  Comparison of disability rates among older adults in aggregated and separate Asian American/Pacific Islander subpopulations.

Authors:  Esme Fuller-Thomson; Sarah Brennenstuhl; Marion Hurd
Journal:  Am J Public Health       Date:  2010-03-18       Impact factor: 9.308

Review 3.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

4.  A common SCN5A variant is associated with PR interval and atrial fibrillation among African Americans.

Authors:  Leonard Ilkhanoff; Dan E Arking; Rozenn N Lemaitre; Alvaro Alonso; Lin Y Chen; Peter Durda; Stephanie E Hesselson; Kathleen F Kerr; Jared W Magnani; Gregory M Marcus; Renate B Schnabel; J Gustav Smith; Elsayed Z Soliman; Alexander P Reiner; Nona Sotoodehnia
Journal:  J Cardiovasc Electrophysiol       Date:  2014-08-25

5.  Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.

Authors:  Benjamin A Goldstein; Cristina M Arce; Mark A Hlatky; Mintu Turakhia; Soko Setoguchi; Wolfgang C Winkelmayer
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

6.  Genetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL).

Authors:  Gerald S Bloomfield; Tecla M Temu; Constantine O Akwanalo; Peng-Sheng Chen; Wilfred Emonyi; Susan R Heckbert; Myra M Koech; Imran Manji; Changyu Shen; Matteo Vatta; Eric J Velazquez; Jennifer Wessel; Sylvester Kimaiyo; Thomas S Inui
Journal:  Am Heart J       Date:  2015-06-14       Impact factor: 4.749

7.  Racial differences in the incidence of and risk factors for atrial fibrillation in older adults: the cardiovascular health study.

Authors:  Paul N Jensen; Evan L Thacker; Sascha Dublin; Bruce M Psaty; Susan R Heckbert
Journal:  J Am Geriatr Soc       Date:  2013-01-15       Impact factor: 5.562

8.  Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Authors:  Utibe R Essien; DaJuanicia N Holmes; Larry R Jackson; Gregg C Fonarow; Kenneth W Mahaffey; James A Reiffel; Benjamin A Steinberg; Larry A Allen; Paul S Chan; James V Freeman; Rosalia G Blanco; Karen S Pieper; Jonathan P Piccini; Eric D Peterson; Daniel E Singer
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

9.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

10.  Racial Differences in the Prevalence and Outcomes of Atrial Fibrillation in Patients Hospitalized With Heart Failure.

Authors:  Subir Bhatia; Mohammad Qazi; Ashwini Erande; Kunjan Shah; Alpesh Amin; Pranav Patel; Shaista Malik
Journal:  Am J Cardiol       Date:  2016-02-17       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.